NCT00132158: ZD1839 and Oral Irinotecan in Treating Young Patients With Refractory Solid Tumors |
|
|
| Completed | 1 | 19 | US | Irinotecan (Camptosar), Gefitinib (Iressa) | St. Jude Children's Research Hospital, AstraZeneca | Glioblastoma, Rhabdomyosarcomas, Neuroblastoma, Osteosarcoma | 10/11 | 10/11 | | |
